Literature DB >> 17399642

Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.

Regina Bökenkamp1, Arthur A Wilde, Martin J Schalij, Nico A Blom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17399642     DOI： 10.1016/j.hrthm.2006.12.031

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  16 in total

Review 1.  The risk of cardiac events and genotype-based management of LQTS patients.

Authors:  Grazyna Markiewicz-Łoskot; Ewa Moric-Janiszewska; Urszula Mazurek
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

2.  Effect of flecainide on T-wave alternans in Andersen-Tawil syndrome.

Authors:  Hideki Hayashi; Tamiro Kawaguchi; Minoru Horie
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07       Impact factor: 1.468

Review 3.  Kir 2.1 channelopathies: the Andersen-Tawil syndrome.

Authors:  Martin Tristani-Firouzi; Susan P Etheridge
Journal:  Pflugers Arch       Date:  2010-03-21       Impact factor: 3.657

4.  Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.

Authors:  Akinori Sato; Toshiki Takano; Masaomi Chinushi; Tohru Minamino
Journal:  BMJ Case Rep       Date:  2019-07-15

5.  Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification.

Authors:  Ricardo Caballero; Pablo Dolz-Gaitón; Ricardo Gómez; Irene Amorós; Adriana Barana; Marta González de la Fuente; Lourdes Osuna; Juan Duarte; Angelica López-Izquierdo; Ignacio Moraleda; Enrique Gálvez; José Antonio Sánchez-Chapula; Juan Tamargo; Eva Delpón
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

6.  Long QT syndrome: A therapeutic challenge.

Authors:  Maully Shah; Christopher Carter
Journal:  Ann Pediatr Cardiol       Date:  2008-01

Review 7.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 8.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

Review 9.  Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.

Authors:  Daniel R Swale; Sujay V Kharade; Jerod S Denton
Journal:  Curr Opin Pharmacol       Date:  2013-11-26       Impact factor: 5.547

Review 10.  Congenital Long QT syndrome and torsade de pointes.

Authors:  Nabil El-Sherif; Gioia Turitto; Mohamed Boutjdir
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-07-02       Impact factor: 1.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.